The North America digital health market size was exhibited at USD 94.55 billion in 2023 and is projected to hit around USD 478.34 billion by 2033, growing at a CAGR of 17.6% during the forecast period 2024 to 2033.
Report Scope of The North America Digital Health Market
| Report Coverage | Details |
| Market Size in 2024 | USD 111.19 Billion |
| Market Size by 2033 | USD 478.34 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 17.6% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Technology, Component, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America |
| Key Companies Profiled | Cerner Corp.; Allscripts; Apple Inc; Telefonica S.A.; McKesson Corp.; Epic Systems Corp.; QSI Management, LLC; AT&T; Vodafone Group; Airstrip Technologies; Google, Inc; Samsung Electronics Co. Ltd; Hims; Orange; Qualcomm Technologies, Inc; Softserve; MQure; Computer Programs and Systems, Inc; Vocera Communications; IBM Corp.; CISCO Systems, Inc. |
Favorable consumer perception on telehealth usage is increasing the willingness of healthcare service providers to use digital health and regulatory changes are enabling better reimbursement. These are some of the major factors anticipated to drive the market growth over forecast periods. In addition, the shortage of medical professionals, the growing geriatric population, and the increasing prevalence of chronic diseases, such as diabetes, cancer, and Cardiovascular Disorders (CVDs), are also expected to boost the adoption of remote patient monitoring platforms over the years.
Moreover, high penetration of smartphones and the internet, improved healthcare digitalization, increasing preference for virtual healthcare services are some factors supporting the market growth. Furthermore, increasing digital transformation of healthcare systems incorporating hardware, software, and services is anticipated to boost the market growth. The growing demand for efficient and quick healthcare services using smartphones and other platforms, such as computers and tablets, is further expected to complement the industry growth. A rise in smartphone users and the frequent launch of novel mobile healthcare apps with better functionality are also supporting the market growth.
For instance, in August 2021, Abbott received the U.S. Food and Drug Administration (FDA) approval for its iPhone-compatible FreeStyle Libre 2 iOS application for Continuous Glucose Monitoring (CGM). This app enables remote monitoring of glucose readings of patients and gets real-time alarms to manage diabetes. The growing prevalence of several chronic diseases, such as cancer, heart disease, hypertension, stroke, diabetes, and respiratory diseases, which can lead to hospitalization or long-term care, is also driving the market. The shortage of healthcare professionals and the growing requirement for long-term care for chronic disease patient management boosts the preference for remote patient monitoring services, which, in turn, is anticipated to fuel the market growth over the coming years.
For instance, according to The U.S. Centers for Disease Control and Prevention (CDC), 6 in 10 Americans have at least one chronic disease. Furthermore, according to the National Health Council report, more than 40% of the population in the U.S. is affected by incurable or ongoing chronic diseases. In addition, the digital healthcare platforms enable virtual consultation among the healthcare professionals and patients, which provides benefits, such as shorter hospital stay, self-management, improvement in the quality of life, and reduction in healthcare expenses, thereby driving the market growth. Furthermore, increasing government initiatives on the development of virtual healthcare platforms to provide services & support for better patient care in remote locations, through online social platforms, and mobile device apps are also driving the market growth.
For instance, in August 2021, the U.S. government invested USD 19 million to expand telehealth quality nationwide and improve telehealth services in rural and other underserved communities. Such types of initiatives through digital platforms by the government to provide improved health quality and timely clinical assessment and treatment to the most vulnerable populations of the region are, in turn, anticipated to accelerate the market growth. The government-imposed shutdown and lockdowns in the region and increased usage of remote healthcare services through digital health platforms during the COVID-19 pandemic drove the market growth in 2021.
In addition, the rapid advancement of information and communication technology using portable electronic devices for remote patient monitoring and Electronic Health Records (EHRs) management to improve the decision-making process without in-person visits, in turn, boosted the market growth during the pandemic. The COVID-19 pandemic has made digital health platforms, such as telehealth, mHealth, telemedicine, and telecare, the basic need for healthcare providers and patients with chronic diseases. Benefits of remote healthcare platforms, such as the reduced risk of direct contamination of pathogens, improved access to care, and minimized use of healthcare resources, have also propelled the market growth in 2021.
The telehealthcare segment accounted for the highest share of more than 44.2% of the total revenue in 2023. This share is attributed to the high adoption of the technology for treating, diagnosing, and controlling diseases during the COVID-19 pandemic. The segment is also anticipated to register the fastest CAGR over the forecast years due to the increased preference by patients and healthcare providers to use low-cost virtual disease management using telehealth platforms. In addition, growing promotion by the medical professionals to adopt telehealth platforms for better patient engagement is anticipated to drive the segment further during the forecast years.
Increasing investments by manufacturers to develop improved telehealth platforms for better remote patient monitoring and self-diagnostics services also support the segment growth. For instance, in January 2021, Teladoc Health and Dexcom collaborated and introduced CGM technology to offer real-time health recommendations for Type 2 diabetic patients. In addition, the broad application of the telehealth platform to manage several disease conditions of vulnerable people and patients from remote locations is anticipated to accelerate the segment growth during the forecast years.
The services component segment dominated the market in 2023 and accounted for the largest share of more than 32.0% of the overall revenue. This share is attributed to the growing preference for training, staffing, resource allocation, optimization, and maintenance of digital health platforms. The increasing services of post-installation and pre-installation of the healthcare component offered by the key players are also expected to accelerate the segment growth over the forecast years. In addition, increasing expectations of the consumers to get better digital platforms and the growing focus of market players on providing better services are the major factors expected to drive the segment growth over the forecast period.
On the other hand, the fastest growth rate is expected from the software segment over the forecast years owing to the rapid development of improved healthcare software by key market players. In addition, rapid adoption of several applications or software among providers, patients, healthcare institutions, and insurance payers is anticipated to drive the growth of this segment over the years to come. Moreover, the increasing trend of healthcare digitalization and the introduction of new software are anticipated to fuel the segment growth further during the estimated period.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the North America digital health market
Technology
Component
Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers